Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Revenue (2016 - 2023)

Historic Revenue for RedHill Biopharma (RDHL) over the last 12 years, with Q2 2023 value amounting to $1.8 million.

  • RedHill Biopharma's Revenue fell 9021.04% to $1.8 million in Q2 2023 from the same period last year, while for Dec 2024 it was $1.8 million, marking a year-over-year decrease of 9012.81%. This contributed to the annual value of $8043.0 billion for FY2024, which is 12316988468.61% up from last year.
  • Per RedHill Biopharma's latest filing, its Revenue stood at $1.8 million for Q2 2023, which was down 9021.04% from $3.6 million recorded in Q1 2023.
  • Over the past 5 years, RedHill Biopharma's Revenue peaked at $22.1 million during Q4 2021, and registered a low of $1.1 million during Q1 2020.
  • Its 5-year average for Revenue is $12.4 million, with a median of $15.3 million in 2022.
  • Its Revenue has fluctuated over the past 5 years, first surged by 184839.02% in 2021, then crashed by 9021.04% in 2023.
  • Over the past 5 years, RedHill Biopharma's Revenue (Quarter) stood at $1.6 million in 2019, then soared by 1249.75% to $21.5 million in 2020, then rose by 2.84% to $22.1 million in 2021, then tumbled by 42.01% to $12.8 million in 2022, then crashed by 85.97% to $1.8 million in 2023.
  • Its Revenue was $1.8 million in Q2 2023, compared to $3.6 million in Q1 2023 and $12.8 million in Q4 2022.